Is Candida kefyr an Emerging Pathogen in Patients with Oncohematological Diseases?
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
TOTHE EDITOR—We read with interest the report by Reuter et al. [1], who documented 3 cases of nosocomial Candida kefyr bloodstream infection in patients with neutropenic leukemia. We report a particularly high prevalence of C. kefyr colonization in patients with oncohematological diseases at our hospitals. During a 6-year period (2000–2005), a total of 64,417 isolates of Candida species were collected from 3 French teaching hospitals with 4150 beds, including 305 oncohematological unit beds. A total of 12,834 (20%) of 64,417 Candida isolates were recovered from patients hospitalized in oncohematology wards. Surprisingly, C. kefyr was isolated twice as often from patients in oncohematology wards than from those hospitalized in other wards (4.8% vs. 1.9%; P < .001) (table 1). Among the 1604 C. kefyr isolates recovered during this period, 623 (38.8%) were isolated from patients in oncohematology wards (P < .001). During the same period, 10 patients developed a C. kefyr bloodstream infection, of whom 9 (90%) were hospitalized in oncohematology wards. Most patients (7 of 9) had myeloid or lymphoblastic leukemia. Previous investigations of Candida transmission have shown that the gut is the main source of candidemia in patients with hematological malignancies [2]. In this population, >60% of candidemia episodes are due to non-albicans Candida species [3–5], although the reasons for the predominance of these species remain unknown. In the same way, the reasons why C. kefyr is an emergent yeast in the fungal flora of neutropenic patients are not known, because the gastrointestinal flora of healthy individuals is composed of mainly of Candida albicans and Candida glabrata [6]. Even if C. kefyr is found on certain foodstuffs (mainly dairy products) [7], it is not known why this yeast is isolated more frequently from patients with oncohematological diseases. We can hypothesize that (1) the use of empirical therapeutics as well as antifungal prophylaxis could induce selection of C. kefyr in gastrointestinal flora, because some strains of C. kefyr have high MICs of amphotericin B [8]; and (2) colonization of neutropenic patients with C. kefyr could be favored by modifications in gastrointestinal homeostasis—in particular, by the induction of mucositis by antimycotics (i.e., mucositis could favor colonization by C. kefyr). Distribution of Candida kefyr strains isolated from hospitalized patients in 3 French teaching hospitals during 2000–2005. The shift toward infections caused by non-albicans Candida species is well documented in neutropenic patients, and C. kefyr plays a significant role in these infections. The mechanisms that determine the adaptation and persistence of this species in patients who have hematological malignancies remain to be determined, as do the virulence factors that contribute to the pathogenicity of C. kefyr. We thank Nadine François (CHRU Lille) for her help with the collection of data. Potential conflicts of interest. All authors: no conflicts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509
Cited by
Emerging opportunistic yeast infections
Miceli, M. H., Díaz, J. A., & Lee, S. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70218-8 · Cited by 811
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524
“kefyr colonisation in patients with onco-haematological diseases [53].”
BackgroundPfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396
“kefyr has been called an ‘emerging’ pathogen in patients with leukemia and neutropenia based on two reports documenting nosocomial BSI and colonization [55,56].”
Background
Metadata
- Authors
- Sendid, B., Lacroix, C., & Bougnoux, M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09
- Volume
- 43
- Issue
- 5
- Pages
- 666-667
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2130422522
- Cited by
- 37
- References
- 2
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is Candida kefyr an Emerging Pathogen in Patients with Oncohematological Diseases? https://app.cochat.ai/papers/10.1086/506573
- The paper
- Sendid, B., Lacroix, C., & Bougnoux, M. (2006). Is Candida kefyr an Emerging Pathogen in Patients with Oncohematological Diseases? Clinical Infectious Diseases. https://doi.org/10.1086/506573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.